The Art of Decentralizing Pediatric Rare Disease Studies: Clinical Trials Suited for Daily Life

Meet Our Speakers:

Betsy Reid
Senior Vice President, Pediatrics

Adam Bloomfield, MD, FAAP
Executive Director, Medical Affairs, Rare Diseases and Pediatrics

Medical and Regulatory Affairs

FDA’s Final Rule on LDTs and Its Impact on Clinical and Regulatory Professionals

By Charles Chrisawn

April 30, 2024

Consulting

3 Characteristics of a Successful Cell and Gene Therapy Nonclinical Program

By Madelyn Huang

April 24, 2024

Enhancing Clinical Trial Accessibility – Bringing Oncology Trials to Patients

Listen Now